Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant-Reference-Cited by-同舟云学术

Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant

Published:2024-06 Issue:6 Volume:30 Page:608.e1-608.e10
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Solomon Scott R.^ORCID,Aubrey Michael T.^ORCID,Bachier-Rodriguez Lizamarie,Solh Melhem M.,Jackson Katelin C.,Zhang Xu^ORCID,Roark Christina L.^ORCID,Holland H. Kent,Morris Lawrence E.,Bashey Asad

Publisher

Elsevier BV

Reference26 articles.

1. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years;Passweg;Bone Marrow Transplant,2021

2. Current use of and trends in hematopoietic cell transplantation in the United States;D'Souza;Biol Blood Marrow Transplant,2020

3. Impact of donor age and kinship on clinical outcomes after T-cell–replete haploidentical transplantation with PT-Cy;Mariotti;Blood Adv,2020

4. Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide;DeZern;Blood Adv,2021

5. Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10 years at a single institution;Wu;Br J Haematol,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From clones to immunopeptidomes: New developments in the characterization of permissive HLA-DP mismatches in hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-09